The incidence of cutaneous malignant melanoma (MM) is increasing worldwide.1-2 Regular self-skin examination can assist in the early detection of MM. However, identifying new or changing lesions on non-visible body sites (NVBS) can be difficult. Often patients are unaware of lesions on NVBS which are identified incidentally during total body examination (TBE) by a Dermatologist. Research investigating MM on NVBS is limited.3 The aim of this study is to compare features of MM on NVBS to visible body sites (VBS) to add data to this patient cohort.
We performed a retrospective chart review identifying patients diagnosed with MM in our institution from 2019–2021. Patients were identified through multidisciplinary meeting records with data drawn from electronic reports and photography.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
